Clinical Trial Update: A Phase Ⅱa Study of the Safety, Tolerability and Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis [Phase 2]

View source ↗

Summary

A Phase 2a clinical trial is evaluating the safety, tolerability, and efficacy of BD111 for herpes simplex keratitis caused by HSV-1; the study is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Simplex Keratitis

Drugs mentioned

• BD111

Snippet

Sponsor: Shanghai BDgene Co., Ltd. | Conditions: Herpes Simplex Virus Type I Stromal Keratitis | Phase 2 | Status: RECRUITING